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Abstract
Background: Different techniques have been used for the guidance of nonpalpable breast cancer (NBC), but none
of them has yet achieved perfect results. The aim of this study was to evaluate the feasibility of indocyanine green
(ICG) fluorescence-guided nonpalpable breast cancer lesion excision (IFNLE), to introduce an alternative technique.
Methods: The data about 56 patients with preoperatively diagnosed NBCs operated with the help of intraoperative
IFNLE between November of 2010 and September of 2014 were retrospectively analyzed.
Results: ICG fluorescence localized all lesions at surgery. Re-excision due to positive resection margins was necessary in
two patients (3.6 %; 2/56) with ductal carcinoma in situ (DCIS) at the surgical margins. Mastectomy was necessary in one
patient (1.8 %; 1/56) due to multifocal invasive carcinoma. The mean volume of the excised tissue was 38.2 ± 16.5 cm3.
Conclusions: IFNLE is a technically applicable and clinically acceptable procedure whenever a breast cancer needs
image-guided excision.
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Background
Breast cancer diagnosis has undergone a dramatic evolu-
tion in the last few decades. Due to the emergent avail-
ability in mammography screening programs, there has
been a rapid increase in the diagnosis of nonpalpable
breast cancer (NBC) to the breast surgeon [1]. Diagnosis
is therefore more often made at an early stage, which is
associated with decreased incidence of lymph node in-
volvement. A suitable treatment for early stage breast
cancer is breast-conserving surgery (BCS) [2, 3].
For breast-conserving treatment of NBC, an accurate in-
traoperative guidance is essential to achieve complete
tumor removal with acceptable cosmetic results [4]. Trad-
itionally, the surgical excision of this kind of lesion has been
carried out with some methods; however, each technique
suffers from various limitations [5–7]. Recently, a novel
method of using indocyanine green (ICG) fluorescence has
been described in breast surgery [8, 9].
In this article, we designed our study to evaluate the
usefulness of ICG fluorescence-guided nonpalpable
breast cancer lesion excision (IFNLE) and its results, to
see whether the technique can be accepted as an alterna-
tive method of image guidance for the procedure.
Methods
Sample collection
Between November of 2010 and September of 2014, 56
patients with histologically diagnosed NBCs who under-
went IFNLE were included in this retrospective analysis.
Patients of benign lesions removed with the help of pre-
operative ultrasonography (US) were excluded from the
study. Written consent was obtained from all partici-
pants, and the study was approved by the institutional
ethics committee of Dalian Central Hospital before the
operation.
Lesion localization
Before surgery, image guidance was done by US with a
10-MHz linear transducer (Voluson 730 Expert; GE
Healthcare, Chalfont St Giles, UK). Breast US provided
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specific information regarding the tumor location, extent
and its longest diameter, the tumor depth from the skin,
and distance from the pectoralis muscle. Under local
anesthesia, a 22-gauge spinal needle was placed through
the lesion long axis into its center, and 2 ml (10 mg) of
ICG solution (Diagnogreen, Daiichi pharmaceutical,
Tokyo, Japan) was injected intralesionally (Fig. 1).
Correct localization was confirmed by US with the help
of the dynamic change in echogenicity of the lesion after
ICG injection.
ICG fluorescence-guided breast lesion excision
The photodynamic eye (PDE; manufactured by Hamamatsu
Japan) was used as the intraoperative ICG fluorescence-
guided device. After the surgical lights were turned off, the
surgeon localized the tumor under PDE guidance and de-
termined in an incision line. The surgeon identified and
marked the site of the skin incision with a suitable pen by
observing the area of ICG fluorescence. During the surgery,
the first assistant held the PDE at a distance of 20–30 cm
from the breast (Fig. 2). Following the skin incision, dissec-
tion was carried out toward the injected ICG covering the
lesion, and the resection margins were defined with fluores-
cence imaging (Fig. 3). After the lesion was excised, the
PDE was used to examine the bed to verify that there were
no residual areas of fluorescence. If there was any site that
emits a strong fluorescence, that site was removed along
with the surrounding tissue. If the lesion depth from the
skin was more than 10 mm, a second injection with a
smaller dose of ICG solution (0.2 ml) was placed into the
subcutaneous tissue projection of the lesion in order to
achieve a better visualization of the fluorescence during the
surgery.
All surgical specimens underwent mammographic or
US study to verify a complete removal of lesions within
the specimen. The all excised samples were also marked
with blue and black ink to orientate the anterior and
posterior surfaces, respectively. Histological examination
of the specimens was performed at the pathology depart-
ment. Thorough examination included the measurement
of the specimen in three dimensions, evaluation of the
greatest tumor diameter, and margin status with docu-
mentation of the closest margin in addition to the deter-
mination of the final histological diagnosis. All resected
tissue was evaluated by standard hematoxylin and eosin
staining.
Results
US localization took very little time (8–10 min). The re-
sult of preoperative diagnostic US for tumor dimensions
was satisfactory. The sizes of the lesions measured on
the US ranged from 0.6 to 2.1 cm (mean ± SD, 1.3 ±
0.5 cm). Patients and tumor characteristics are listed in
Table 1. The ICG-guided localization correctly identified
all target lesions at the initial surgery (there was no
missed lesion), yielding a 100 % positive predictive value
for the lesions. There was no false-positive localization.
Satisfactory margins (defined as no re-excision necessary)
were found in 94.6 % (53/56) of patients. Re-excision due
to positive resection margins was necessary in two patients
with ductal carcinoma in situ (DCIS) at the surgical mar-
gins. In addition, mastectomy was necessary in one patient
1.8 % (1/56) due to multifocal invasive carcinoma unknown
at time of ICG-guided excision. Thus, two patients required
surgical re-excision, one required mastectomy, and the
re-excision rate for all ICG-guided procedures was
5.4 % (3/56). There was an additional patient who had
focal carcinoma at a margin and did not have further
surgery, and she was an elder woman who had five
clear margins of her 15-mm invasive carcinoma and re-
fused re-excision for an associated focus of in situ car-
cinoma at one margin.
The volume of the excised tissue was calculated from
the three dimensions measured by the pathologist using
the formula 4/(3π) × a × b × c. The mean volume of the
excised tissue was 38.2 ± 16.5 cm3 (Table 2).
On pathological examination, there were six patients
(10.7 %; 6/56) with DCIS and the remaining 50 patients
(89.3 %; 50/56) had invasive disease. US identified only
Fig. 1 Ultrasonographic appearance of a nonpalpable breast lesion: a hypoechoic with irregular margins; b intralesional injection of indocyanine
green (ICG) solution with a spinal needle under ultrasound guidance (arrow)
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two patients with DCIS (33.3 %; 2/6). Thus, DCIS could
not be visible by US in four patients (66.7 %; 4/6).
The mean follow-up was 19 months (range, 6–
38 months). Patients underwent physical examination
and mammogram of the affected breast every 3 months
for the first 2 years. Thereafter, the same examinations
occurred every 6 months. During the time of follow-up,
no patient had local or systemic recurrence.
Discussion
To date, several different techniques have been de-
scribed for the localization of nonpalpable breast lesion
[10–12], the most common being the introduction of a
wire-guided localization (WGL) [6]. The downsides of
this method are the displacement or deviation of the
wire, the possibility of re-intervention due to positive
margin, and patient discomfort [6, 13]. Alternatively,
radio-guided occult lesion localization (ROLL) is usually
performed by a radiologist immediately before the surgi-
cal procedure [5]. Zgajnar et al. [14] reported smaller ex-
cisions with a higher percentage of clear surgical
margins in ROLL compared with WGL. However, even
with ROLL, they still achieved clear margins in 70 % of
56 breast cancer patients. Otherwise, limitations of this
process are many. Scheduling patients both in radiology
and then in surgery may be difficult, and the technique
is impractical at institutions where there is no nuclear
medicine facility [5].
It is, therefore, not surprising that alternative methods
for tumor guidance excision, such as US, have been in-
vestigated [7]. In a comparative study of three different
methods used in BCS of nonpalpable lesions in 201 pa-
tients, Krekel et al. [15] found a significantly lower rate
of positive margins with the use of US guidance (3.7 %)
compared with wire localization (21.5 %) and ROLL
(25 %). Similarly, re-excision rates of from 3.2 to 11.4 %
after intraoperative US guidance of nonpalpable lesions
have been reported by other authors (Table 3) [15–20].
ICG fluorescence has been used as a tracer for many
years and has demonstrated excellent safety profile for
clinical use [21, 22]. The principle of fluorescence meas-
urement is as follows: Injected ICG molecules are
promptly bound to the globulin fractions in serum pro-
teins. Under this condition, when excitation light of
760 nm is irradiated, fluorescence with a peak wave-
length of 845 nm will be emitted. This process is cap-
tured by a fluorescence navigation system using a PDE.
Fluorescence at a depth of 10–15 mm beneath the skin
can be visualized, based on the distance that the light is
able to reach [23].
Today, most of the reports for ICG fluorescence ap-
plied to breast cancer are about the intraoperative iden-
tification of sentinel lymph node (SLN). The technique
is feasible and accurate with acceptable sensitivity and
specificity, comparable to conventional node detection
methods [23, 24]. Meanwhile, there are theoretical and
Fig. 2 a During surgery, a near-infrared-sensitive imaging system was used to observe. b The area of ICG-derived fluorescence
Fig. 3 a The resection margins were defined under the guidance of fluorescence imaging; b appearance of the specimen after excision
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practical advantages about the fluorescence navigation
technique as a guidance to the surgical excision of
NBCs. However, the only report about IFNLE was de-
scribed in 2012 by Aydogan F and associates [25], who
used the technique as a guidance for the excision of
NBCs in two cases, and had achieved clear margins. This
study summarizes our experience using the method in
56 cases.
The presented method, which we termed IFNLE, shares
the similar technical principle with ICG-guided SLN bi-
opsy. The key point of IFNLE is that ICG is injected dir-
ectly into the center of the lesion under US localization.
Subsequently, dissection is carried out, and resection mar-
gins are defined by observing the fluorescence areas with a
near-infrared camera. One could theorize that real-time
imaging during the whole procedure allows for a very ac-
curate determination of margins around the tumor by
direct visualization of ICG fluorescence. By using this
technique, the breast lesions were correctly localized, the
fluorescent areas corresponded well to the sites of lesion,
and we excised all of the breast lesion successfully just one
time (Fig. 3). If the breast lesion was located deeper, for
example more than 10 mm, in addition to intralesional in-
jection, a much smaller dose of ICG (0.2 ml) can also be
injected into the subcutaneous tissue projection of the le-
sion in order to enhance fluorescence visualization.
In our study, re-excisions were required for positive
margins in only two patients (3.6 %) and mastectomy
was necessary in one patient (1.8 %) (Table 2). Thus,
the re-excision rate for all IFNLE procedures was 5.4 %
(3/56) which is comparable to other series of US
localization and better than that of WGL (Table 3). The
pathological finding in three patients required re-
excisions with one calcified DCIS, one noncalcified
DCIS at the surgical margins, and multifocal invasive
carcinoma in the one case (underwent mastectomy).
This conforms to Cary et al. [11] who found that re-
gardless of the type of imaging guidance, patients with
DCIS or multifocal invasive cancer will be at increased
risks for a positive margin, re-excision, or mastectomy.
Until now, the volumes of excised specimens were re-
ported in only a few studies with nonpalpable lesions.
The mean total resection volume ranged from 42 to
71 cm3 with US and 54 to 63 cm3 with WGL (Table 3).
Because US guidance and excision of the lesion cannot
be performed simultaneously and there is no guide wire
to see or feel during the procedure, it may be also diffi-
cult for a surgeon to define the tumor margins accur-
ately, especially for women with large breasts and deeply
seated lesions. In order to ensure a negative margin, the
surgeon usually excised a wide and deep margin around
the tumor, leading to excessive tissue excision [26, 27].
Owing to the displacement of the wire or inaccurate
wire localization, unnecessary large volumes of tissue
will be removed by WGL technique [6, 13].
Otherwise, the PDE need not touch the breast by the
ICG fluorescent guidance; it can constantly provide a
direct visualization during the whole excision, which has
the potential to overcome the weak points of US or
WGL [25]. In the present study, the mean resection vol-
ume is only 38 cm3 which indicates that a small amount
Table 1 Patient and tumor characteristics
Characteristic Value and percentage
No. of patients 56
Median age (range), years 53.8 (34–78)
Tumor diameter, mean ± SD (cm) 0.6–2.1 cm, 1.3 ± 0.5
Grade
1 10 (17.8 %)
2 31 (55.4 %)
3 15 (26.8 %)
Accurate location of breast cancer 56 (100 %)
Margins of excision
Satisfactory 53 (94.6 %)
Unsatisfactory 3 (5.4 %)
Tumor type on US examination
DCIS 2 (3.6 %)
Invasive carcinoma 54 (96.4 %)
Tumor type on pathological examination
DCIS 6 (10.7 %)
Invasive carcinoma 50 (89.3 %)
Node status (both physical and US examination)
Negative nodes 45 (80.4 %)
Positive nodes 11 (19.6 %)
DICS ductal carcinoma in situ
Table 2 Marginal status of excision and volumes of the specimens in the patients
Characteristic Histological diagnosis in re-excision specimen n (%) Mean volume ± SD (cm3)
No re-excision (including one focal positive case) 53 (94.6 %)
Re-excision 3 (5.4 %)
DICS 2 (3.6 %)
Multifocal invasive cancer (mastectomy) 1 (1.8 %)
Excision specimens 38.2 ± 16.5
DICS ductal carcinoma in situ
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of the healthy breast tissue unnecessarily sacrificed was
removed. We have demonstrated that IFNLE method
enables the resection of smaller volumes of the tissue
with a low re-excision rate. So another main benefit of
the technique is the ability to limit the amount of ex-
cised normal tissue while achieving adequate distance
from the lesion to the surgical margin, and therefore,
specimen volume will be minimized. This is important
not only for the success rate of the procedure but also
for the cosmetic outcome in breast-conservation treat-
ment [28, 29].
The benefits of IFNLE are as follows: (1) the site of
the skin incision can be defined precisely; (2) infrared
fluorescence image makes it easy to recognize the resec-
tion margins of the breast lesion; and (3) the method of
IFNLE facilitates visualization of the whole process of
excising the lesion in real time during surgery, and the
volume of resection may be smaller.
However, the method also has several problems such
as (1) this method cannot be applied to patients with
hypersensitivity to iodine because the commercially
available product contains approximately 5 % sodium
iodides as a contaminant and (2) ICG tattooing lasted 10
to 14 days before disappearing spontaneously [8].
Our study also has several limitations. Most import-
antly, it is a retrospective series of observation without a
control group. Though some advantages of IFNLE seem
obvious, a prospective randomized study is needed to
gain more reliable information, and we are planning to
conduct such a study in the future.
Conclusions
IFNLE proved to be a reliable and very useful tool to ex-
cising NBCs, improving the process of image-guided
surgery. It is accurate and technically feasible, and the
re-excision rate is lower with less the volume of healthy
breast tissue unnecessarily sacrificed. It simplifies
organizational work and spares the patient from discom-
fort of preoperative needle localization and drawbacks of
US-guided excision or ROLL. Although further studies
assessing the feasibility and validation of this technique
are required, intraoperative ICG-guidance should be
considered whenever a breast cancer needs image-
guided excision.
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